Northern Trust’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.21M | Buy |
765,273
+15,286
| +2% | +$168K | ﹤0.01% | 2258 |
|
|
2025
Q4 | $9.31M | Sell |
749,987
-64,352
| -8% | -$856K | ﹤0.01% | 2121 |
|
|
2025
Q3 | $11.7M | Buy |
814,339
+71,180
| +10% | +$975K | ﹤0.01% | 2026 |
|
|
2025
Q2 | $9.12M | Sell |
743,159
-132,064
| -15% | -$1.92M | ﹤0.01% | 2128 |
|
|
2025
Q1 | $19.2M | Sell |
875,223
-17,202
| -2% | -$404K | ﹤0.01% | 1651 |
|
|
2024
Q4 | $20.2M | Buy |
892,425
+80,090
| +10% | +$1.75M | ﹤0.01% | 1679 |
|
|
2024
Q3 | $14.8M | Buy |
812,335
+308,198
| +61% | +$7.14M | ﹤0.01% | 1821 |
|
|
2024
Q2 | $14.7M | Sell |
504,137
-28,891
| -5% | -$857K | ﹤0.01% | 1756 |
|
|
2024
Q1 | $18.9M | Sell |
533,028
-62,438
| -10% | -$2.5M | ﹤0.01% | 1633 |
|
|
2023
Q4 | $25.9M | Sell |
595,466
-26,142
| -4% | -$1.03M | ﹤0.01% | 1434 |
|
|
2023
Q3 | $23.7M | Sell |
621,608
-19,382
| -3% | -$815K | ﹤0.01% | 1431 |
|
|
2023
Q2 | $26.4M | Sell |
640,990
-24,682
| -4% | -$1.19M | 0.01% | 1406 |
|
|
2023
Q1 | $38.2M | Sell |
665,672
-13,120
| -2% | -$739K | 0.01% | 1131 |
|
|
2022
Q4 | $38.1M | Sell |
678,792
-2,705
| -0.4% | -$138K | 0.01% | 1114 |
|
|
2022
Q3 | $28.9M | Buy |
681,497
+34,237
| +5% | +$1.75M | 0.01% | 1214 |
|
|
2022
Q2 | $35M | Sell |
647,260
-14,046
| -2% | -$844K | 0.01% | 1135 |
|
|
2022
Q1 | $42.5M | Sell |
661,306
-10,320
| -2% | -$679K | 0.01% | 1144 |
|
|
2021
Q4 | $45M | Sell |
671,626
-12,916
| -2% | -$874K | 0.01% | 1184 |
|
|
2021
Q3 | $46.9M | Sell |
684,542
-19,023
| -3% | -$1.34M | 0.01% | 1127 |
|
|
2021
Q2 | $48M | Sell |
703,565
-18,597
| -3% | -$1.32M | 0.01% | 1171 |
|
|
2021
Q1 | $49.9M | Buy |
722,162
+20,387
| +3% | +$1.38M | 0.01% | 1126 |
|
|
2020
Q4 | $45.6M | Buy |
701,775
+51
| +0% | +$2.74K | 0.01% | 1144 |
|
|
2020
Q3 | $33.1M | Sell |
701,724
-12,886
| -2% | -$613K | 0.01% | 1222 |
|
|
2020
Q2 | $33.6M | Buy |
714,610
+10,098
| +1% | +$496K | 0.01% | 1202 |
|
|
2020
Q1 | $31.5M | Buy |
704,512
+28,532
| +4% | +$1.5M | 0.01% | 1089 |
|
|
2019
Q4 | $39.4M | Buy |
675,980
+12,636
| +2% | +$752K | 0.01% | 1191 |
|
|
2019
Q3 | $39.8M | Sell |
663,344
-21,754
| -3% | -$1.3M | 0.01% | 1147 |
|
|
2019
Q2 | $38.3M | Buy |
685,098
+17,262
| +3% | +$889K | 0.01% | 1200 |
|
|
2019
Q1 | $37.2M | Buy |
667,836
+60,122
| +10% | +$3.06M | 0.01% | 1206 |
|
|
2018
Q4 | $27.4M | Buy |
607,714
+6,799
| +1% | +$373K | 0.01% | 1311 |
|
|
2018
Q3 | $39.6M | Sell |
600,915
-54,745
| -8% | -$3.4M | 0.01% | 1205 |
|
|
2018
Q2 | $42.2M | Sell |
655,660
-209,297
| -24% | -$13M | 0.01% | 1164 |
|
|
2018
Q1 | $47.9M | Sell |
864,957
-5,420
| -0.6% | -$284K | 0.01% | 1027 |
|
|
2017
Q4 | $41.7M | Sell |
870,377
-18,390
| -2% | -$900K | 0.01% | 1126 |
|
|
2017
Q3 | $44.9M | Sell |
888,767
-2,045
| -0.2% | -$105K | 0.01% | 1043 |
|
|
2017
Q2 | $48.6M | Buy |
890,812
+50,824
| +6% | +$2.43M | 0.01% | 956 |
|
|
2017
Q1 | $35.4M | Sell |
839,988
-35,540
| -4% | -$1.52M | 0.01% | 1190 |
|
|
2016
Q4 | $37.6M | Buy |
875,528
+92,326
| +12% | +$3.75M | 0.01% | 1105 |
|
|
2016
Q3 | $32.3M | Buy |
783,202
+40,634
| +5% | +$1.7M | 0.01% | 1181 |
|
|
2016
Q2 | $29.6M | Buy |
742,568
+86,180
| +13% | +$3.1M | 0.01% | 1190 |
|
|
2016
Q1 | $22M | Buy |
656,388
+5,116
| +0.8% | +$159K | 0.01% | 1428 |
|
|
2015
Q4 | $22.1M | Buy |
651,272
+3,970
| +0.6% | +$124K | 0.01% | 1432 |
|
|
2015
Q3 | $19.3M | Sell |
647,302
-60,174
| -9% | -$1.88M | 0.01% | 1518 |
|
|
2015
Q2 | $19.5M | Sell |
707,476
-9,935
| -1% | -$265K | 0.01% | 1609 |
|
|
2015
Q1 | $18.1M | Buy |
717,411
+2,973
| +0.4% | +$70.3K | 0.01% | 1659 |
|
|
2014
Q4 | $15.8M | Sell |
714,438
-37,554
| -5% | -$761K | ﹤0.01% | 1720 |
|
|
2014
Q3 | $15.3M | Buy |
751,992
+21,441
| +3% | +$427K | ﹤0.01% | 1714 |
|
|
2014
Q2 | $14.1M | Sell |
730,551
-57,922
| -7% | -$1.08M | ﹤0.01% | 1797 |
|
|
2014
Q1 | $14.8M | Sell |
788,473
-44,810
| -5% | -$865K | ﹤0.01% | 1814 |
|
|
2013
Q4 | $16.3M | Buy |
833,283
+99,840
| +14% | +$1.83M | 0.01% | 1696 |
|
|
2013
Q3 | $12.1M | Sell |
733,443
-8,888
| -1% | -$143K | ﹤0.01% | 1880 |
|
|
2013
Q2 | $11.1M | Buy |
+742,331
| New | +$10.9M | ﹤0.01% | 1838 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Northern Trust's IART Position: Q1 2026 in Review
Northern Trust increased its Integra LifeSciences (IART) stake by 2% in Q1 2026, buying an estimated $168K and bringing the position to 765,273 shares worth $7.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2258.
Northern Trust first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $49.9M in Q1 2021. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Northern Trust held 765,273 shares of Integra LifeSciences worth $7.21M as of Q1 2026.
- Northern Trust bought 15,286 Integra LifeSciences shares in Q1 2026, an estimated $168K.
- Integra LifeSciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2258 holding.
- Northern Trust first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Integra LifeSciences position peaked at $49.9M in Q1 2021.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.